RESEARCH & THOUGHTS
Perspectives Shaping Clinical Development
Discover engaging resources driving the conversation forward and on-demand demo videos showcasing the very solutions forming the future of our field.
In a world where complacency is the enemy of progress, Contract Research Organizations (CROs) stand at...
Read
- Whitepaper
The Principles of Central Statistical Monitoring
- Whitepaper
Ensuring Trial Validity by Data Quality Assurance and Diversification of Monitoring Methods
- Whitepaper
All you need to know about SMART™, the Engine that Drives CluePoints
- Case Study
Using CluePoints to Reveal Protocol Deviations in Patient Selection
- Case Study
The Value of the CluePoints Solution in Identifying Under-reported Adverse Effects in a Clinical Trial
- Case Study
Using CluePoints to Detect Miscalibrated Equipment in a Clinical Trial
- Case Study
Using CluePoints to Identify Fraud Due to the Fabrication of Patient Diaries
- Case Study
Using CluePoints to Identify Severe Propagation in Vital Sign Measurements
- Case Study
Using CluePoints to Detect Anomalies in Electronic Patient-Reported Outcomes
- Case Study
How CluePoints Detected Fraudulent Reporting of Investigational Product Administration from Patient Diary Data
- Case Study
Leveraging Risk-Based Quality Management to Facilitate Early Risk Detection
- Case Study
How CluePoints Enabled Pfizer’s ‘Hyperspeed’ Vaccine Development
- Research Paper
Impact of On-Site Initiation Visits on Patient Recruitment and Data Quality in a Randomized Trial of Adjuvant Chemotherapy for Breast Cancer
- Research Paper
Data Fraud in Clinical Trials
- Research Paper
Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator Outcomes
- Research Paper
Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring
- Blog
ICH E6 R2 – The Clinical R&D Industry’s Response
- Blog
Beyond Risk-Based Monitoring: How Intelligent Analytics Are Being Used To Drive Value And Support ICH Compliance
- Blog
The Bigger Picture Of ICH E6 R2: Looking Beyond Compliance
- Blog
ICH E6 R2: Talking Big Pharma’s Response To The Addendum
- Blog
ICH E6 R2 Roundtable Review – What Does This Mean For The Industry?
- Blog
ICH E6 R2: Waiting And Watching No Longer An Option When It Comes To Risk-Based Monitoring
- Blog
ICH E6 (R2) – Miracle Pill For The Clinical R&D Industry
- Blog
ICH E6 Rev 2 – Ask The Experts
- Blog
Webinar Recording: What Does ICH E6 R2 Mean For Me And My Company?
- Blog
6th Annual CROWN Congress: Sessions You Can’t Afford To Miss + 15% Discount Code
- Blog
Six Ways To Get The Most Out Of Outsourcing In Clinical Trials West Coast ‘17
- Blog
The FDA Is Knocking At Your Door – Are You Ready For An FDA Site Inspection?
